Campbell & Co Investment Adviser’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-11,514
Closed -$1.08M – 1098
2025
Q3
$1.08M Sell
11,514
-25,166
-69% -$2.34M 0.08% 397
2025
Q2
$3.18M Buy
36,680
+32,576
+794% +$2.73M 0.2% 123
2025
Q1
$317K Buy
+4,104
New +$377K 0.02% 837
2023
Q3
– Sell
-7,012
Closed -$531K – 906
2023
Q2
$531K Sell
7,012
-17,552
-71% -$1.18M 0.09% 404
2023
Q1
$1.55M Buy
24,564
+12,486
+103% +$733K 0.29% 52
2022
Q4
$656K Buy
12,078
+2,980
+33% +$177K 0.16% 213
2022
Q3
$520K Buy
+9,098
New +$504K 0.12% 302

Other funds holding ACA

Campbell & Co Investment Adviser's ACA Position: Q4 2025 in Review

Campbell & Co Investment Adviser sold out of Arcosa (ACA) in Q4 2025, closing a stake of 11,514 shares — an estimated $1.08M sold.

Campbell & Co Investment Adviser first reported a position in ACA in Q3 2022 and held it in 7 quarters. The position peaked at $3.18M in Q2 2025. 365 funds tracked by Wall St. Rank hold ACA as of Q4 2025.

  • Campbell & Co Investment Adviser reported no remaining Arcosa position as of Q4 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 11,514 Arcosa shares in Q4 2025, an estimated $1.08M.
  • Campbell & Co Investment Adviser first reported a position in Arcosa in Q3 2022 and held it in 7 quarters.
  • Campbell & Co Investment Adviser's Arcosa position peaked at $3.18M in Q2 2025.
  • 365 funds tracked by Wall St. Rank held Arcosa as of Q4 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2025, filed 12 Feb 2026.